FRANKFURT, April 11 Germany's Merck KGaA
(MRCG.DE) is mulling job cuts at prescription drug unit Merck
Serono to save costs, the Financial Times Deutschland newspaper
reported, citing company sources.
Cutbacks could affect the unit's Swiss headquarters in
particular, the paper added.
Stefan Oschmann took over Merck's prescription drug unit
Merck Serono on Jan. 1 after the unit saw a string of setbacks
in product development.
The European drugs watchdog on Sept. 24 dealt the German
family controlled group a blow by advising against the oral
multiple-sclerosis treatment cladribine in the drug's
potentially largest market. [ID:nLDE68N04J]
Global drugmakers, including Merck & Co (MRK.N), Roche
ROG.VX and Novartis NOVN.VX, have announced job cuts as
approvals for new products are slowing while key drugs are
losing patent protection.
(Reporting by Jonathan Gould; Editing by Louise Heavens)